Leslie’s, Inc. Announces Second Quarter Fiscal 2025 Financial Results; Re-Affirms Full Year Guidance

1 day ago

PHOENIX, May 08, 2025 (GLOBE NEWSWIRE) -- Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the…

Superior Group of Companies Reports First Quarter 2025 Results

1 day ago

– Total net sales of $137.1 million versus $138.8 million in prior year first quarter –– Net (loss) income of…

PubMatic Announces First Quarter 2025 Financial Results; Board of Directors Authorizes $100M Expansion of Share Repurchase Program

1 day ago

Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 20% and was 40% of…

TTM Technologies, Inc. Announces Retirement of Founder and Board Member, Kent Alder

1 day ago

Company Acknowledges Kent Alder’s Visionary Leadership and Remarkable Impact on the Company’s GrowthSANTA ANA, Calif., May 08, 2025 (GLOBE NEWSWIRE)…

Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

1 day ago

– Ongoing clinical studies for four candidates on track with data expected in 2025, including interim Phase 1b data for…

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

1 day ago

Six posters presented at the American Association for Cancer Research (AACR) annual meetingAppointment of Dr. Sabeen Mekan as Senior Vice…

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

1 day ago

Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites…

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

1 day ago

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date…

Sprout Social Announces First Quarter 2025 Financial Results

1 day ago

CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of…

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

1 day ago

Wa'el Hashad Wa'el Hashad, CEO, Longeveron Pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel in HLHS, a rare pediatric…

This website uses cookies.